000 01069 a2200325 4500
005 20250516020112.0
264 0 _c20110131
008 201101s 0 0 eng d
022 _a1527-9995
024 7 _a10.1016/j.urology.2010.05.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Donnell, Peter H
245 0 0 _aEditorial comment.
_h[electronic resource]
260 _bUrology
_cJan 2011
300 _a165-6 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aCystectomy
_xmethods
650 0 4 _aHumans
650 0 4 _aKidney
_xphysiopathology
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPatient Selection
650 0 4 _aPerioperative Care
650 0 4 _aUrinary Bladder Neoplasms
_xdrug therapy
700 1 _aPosadas, Edwin M
773 0 _tUrology
_gvol. 77
_gno. 1
_gp. 165-6
856 4 0 _uhttps://doi.org/10.1016/j.urology.2010.05.008
_zAvailable from publisher's website
999 _c20482221
_d20482221